Skip to main content
. Author manuscript; available in PMC: 2023 Oct 24.
Published in final edited form as: Clin Cancer Res. 2022 Dec 1;28(23):5088–5097. doi: 10.1158/1078-0432.CCR-22-2164

Figure 1.

Figure 1.

Adverse Events attributable to study agents over time grouped by CTCAE v5.0 organ system. Color indicates AE grade and circle size indicates number of patients.